All Stories

  1. DNA fragment conformations in adducts with Kiteplatin
  2. Computational evidence for structural consequences of kiteplatin damage on DNA
  3. Monofunctional Platinum(II) Complexes with Potent Tumor Cell Growth Inhibitory Activity: The Effect of a Hydrogen-Bond Donor/Acceptor N-Heterocyclic Ligand
  4. Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand
  5. Reactivity of kiteplatin with S-donor biomolecules and nucleotides
  6. Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(ii) and rhenium(i) with a ligand targeting the translocator protein (TSPO)
  7. Synthesis, Characterization, and Binding to the Translocator Protein (18 kDa, TSPO) of a New Rhenium Complex as a Model of Radiopharmaceutical Agents
  8. NMR Investigation of the Spontaneous Thermal- and/or Photoinduced Reduction of trans Dihydroxido Pt(IV) Derivatives
  9. A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)
  10. Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum–bisphosphonate complexes in the treatment of bone tumors: A mini-review
  11. Metallo-drugs in the treatment of malignant pleural mesothelioma
  12. Thermodynamic and Mechanistic Insights into Translesion DNA Synthesis Catalyzed by Y-Family DNA Polymerase Across a Bulky Double-Base Lesion of an Antitumor Platinum Drug
  13. Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer
  14. Dinuclear Pt(ii)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs
  15. Nanocrystalline carbonate-apatites: role of Ca/P ratio on the upload and release of anticancer platinum bisphosphonates
  16. Platinum–bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis
  17. Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)]
  18. Platinum(II) Complexes with Bioactive Carrier Ligands Having High Affinity for the Translocator Protein
  19. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand
  20. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours
  21. Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals
  22. A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues
  23. Conformer Distribution in (cis-1,4-DACH)bis(guanosine-5′-phosphate)platinum(II) Adducts: A Reliable Model for DNA Adducts of Antitumoral Cisplatin
  24. Synthesis and Characterization of a Platinum(II) Complex Tethered to a Ligand of the Peripheral Benzodiazepine Receptor
  25. Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds
  26. Novel Therapeutic Agents for Bone Resorption. Part 1. Synthesis and Protonation Thermodynamics of Poly(amido-amine)s Containing Bis-phosphonate Residues
  27. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance
  28. Platinum-Based Antitumor Drugs Containing Enantiomerically Pure α-Trifluoromethyl Alanine as Ligand
  29. Platinum Complexes with the Novel Ligand Diethyl [(Methylsulfinyl)‐methyl]phosphonate (SMP): Solid‐State Characterization of Potassium Trichloro(SMP)platinum( II ) which, in Solution, Gives Dichloro(SMP)‐platinum( ...
  30. Platinum(II) Complexes with Antitumoral/Antiviral Aromatic Heterocycles:  Effect of Glutathione upon in Vitro Cell Growth Inhibition
  31. Synthesis and Characterization of Platinum( II ) Complexes of Diethyl [(Methylsulfinyl)methyl]phosphonate: Potential Drugs against Bone Tumors
  32. Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir
  33. A Molecular Tool for Measuring the Electron‐Acceptor Ability of Ligands from Crystallographic Data
  34. Role of Metal Ions and Hydrogen Bond Acceptorsin the Tautomeric Equilibrium of Nitro‐9[(Alkylamino)Amino]‐Acridine Drugs
  35. Influence of steric and electronic factors in the stabilization of five-coordinate ethylene complexes of platinum(II): X-ray crystal structure of [PtCl2(2,9-dimethyl-1,10-phenanthroline-5,6-dione)]
  36. Mono‐ and Bis‐Guanosine Adducts of Platinum Complexes with Carrier Ligands Having In‐Plane Steric Bulk: The Case of 1,10‐Phenanthroline and 2,9‐Dimethyl‐1,10‐phenanthroline
  37. Addition versus substitution in the reaction of diiodo(2,9-dimethyl-1,10-phenanthroline)platinum(II) with aromatic bases. X-ray crystal structures of the substitution products with 2-amino-pyridine and 1-methyl-cytosine
  38. Synthesis, Characterisation and Antiviral Activity of Platinum(II) Complexes with 1,10-Phenanthrolines and the Antiviral Agents Acyclovir and Penciclovir
  39. Structure and dynamics of a platinum(II) aminophosphine complex and its nucleobase adducts
  40. Influence of Carrier Ligand NH Hydrogen Bonding to the O6 and Phosphate Group of Guanine Nucleotides in Platinum Complexes with a Single Guanine Ligand
  41. Antitumor Trans Platinum DNA Adducts: NMR and HPLC Study of the Interaction Between a trans‐Pt Iminoether Complex and the Deoxy Decamer d(CCTCGCTCTC)·d(GAGAGCGAGG)
  42. Strong, Rapid Binding of a Platinum Complex to Thymine and Uracil Under Physiological Conditions
  43. Starkes und schnelles Binden eines Platinkomplexes an Thymin und Uracil unter physiologischen Bedingungen